Dermatology
1 drug is in development for Generalized Pustular Psoriasis.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Generalized Pustular Psoriasis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
BLA Filed(1)
| Drug | Company |
|---|---|
| imsidolimab | ANAPTYSBIO, INC (ANAB) |
About this indication
Generalized Pustular Psoriasis context
Dermatology·MeSH: Psoriasis (D011565)
Narrower concept of MeSH descriptor Psoriasis
Frequently asked questions
How many drugs are in development for Generalized Pustular Psoriasis?
BioSniper tracks 1 drug in development for Generalized Pustular Psoriasis across 1 company.
How many clinical trials target Generalized Pustular Psoriasis?
There are 8 clinical trials targeting Generalized Pustular Psoriasis tracked by BioSniper.